Luo Y - Search Results

1

Network Pharmacology Approach to Investigate the Mechanism of Danggui-Shaoyao-San against Diabetic Kidney Disease.

Chen Y, Song X, Luo Y, Li G, Luo Y, Wang Z, He R, Lu J, Xiong G, Cheng H, Li H, Yang S. Chen Y, et al. Among authors: luo y. Evid Based Complement Alternat Med. 2023 Jan 3;2023:9208017. doi: 10.1155/2023/9208017. eCollection 2023. Evid Based Complement Alternat Med. 2023. PMID: 36636607 Free PMC article.

2

Systems Pharmacology Approach to Investigate the Mechanism of Kai-Xin-San in Alzheimer's Disease.

Luo Y, Li D, Liao Y, Cai C, Wu Q, Ke H, Liu X, Li H, Hong H, Xu Y, Wang Q, Fang J, Fang S. Luo Y, et al. Front Pharmacol. 2020 Apr 3;11:381. doi: 10.3389/fphar.2020.00381. eCollection 2020. Front Pharmacol. 2020. PMID: 32317964 Free PMC article.

3

Corrigendum: Systems pharmacology approach to investigate the mechanism of Kai-Xin-San in Alzheimer's disease.

Luo Y, Li D, Liao Y, Cai C, Wu Q, Ke H, Liu X, Li H, Hong H, Xu Y, Wang Q, Fang J, Fang S. Luo Y, et al. Front Pharmacol. 2023 Oct 6;14:1239060. doi: 10.3389/fphar.2023.1239060. eCollection 2023. Front Pharmacol. 2023. PMID: 37869758 Free PMC article.

4

A systems pharmacology approach to decipher the mechanism of danggui-shaoyao-san decoction for the treatment of neurodegenerative diseases.

Luo Y, Wang Q, Zhang Y. Luo Y, et al. J Ethnopharmacol. 2016 Feb 3;178:66-81. doi: 10.1016/j.jep.2015.12.011. Epub 2015 Dec 8. J Ethnopharmacol. 2016. PMID: 26680587

5

Danggui-Shaoyao-San (DSS) Ameliorates Cerebral Ischemia-Reperfusion Injury via Activating SIRT1 Signaling and Inhibiting NADPH Oxidases.

Luo Y, Chen H, Tsoi B, Wang Q, Shen J. Luo Y, et al. Front Pharmacol. 2021 Apr 15;12:653795. doi: 10.3389/fphar.2021.653795. eCollection 2021. Front Pharmacol. 2021. PMID: 33935765 Free PMC article.

6

In silico Identification and Mechanism Exploration of Hepatotoxic Ingredients in Traditional Chinese Medicine.

Wu Q, Cai C, Guo P, Chen M, Wu X, Zhou J, Luo Y, Zou Y, Liu AL, Wang Q, Kuang Z, Fang J. Wu Q, et al. Among authors: luo y. Front Pharmacol. 2019 May 3;10:458. doi: 10.3389/fphar.2019.00458. eCollection 2019. Front Pharmacol. 2019. PMID: 31130860 Free PMC article.

7

The Mechanisms of Bushen-Yizhi Formula as a Therapeutic Agent against Alzheimer's Disease.

Cai H, Luo Y, Yan X, Ding P, Huang Y, Fang S, Zhang R, Chen Y, Guo Z, Fang J, Wang Q, Xu J. Cai H, et al. Among authors: luo y. Sci Rep. 2018 Feb 15;8(1):3104. doi: 10.1038/s41598-018-21468-w. Sci Rep. 2018. PMID: 29449587 Free PMC article.

8

Systems pharmacology-based investigation of Sanwei Ganjiang Prescription: related mechanisms in liver injury.

Luo YX, Wang XY, Huang YJ, Fang SH, Wu J, Zhang YB, Xiong TQ, Yang C, Shen JG, Sang CL, Wang Q, Fang JS. Luo YX, et al. Chin J Nat Med. 2018 Oct;16(10):756-765. doi: 10.1016/S1875-5364(18)30115-8. Chin J Nat Med. 2018. PMID: 30322609

9

Angong Niuhuang Wan reduces hemorrhagic transformation and mortality in ischemic stroke rats with delayed thrombolysis: involvement of peroxynitrite-mediated MMP-9 activation.

Chen H, Luo Y, Tsoi B, Gu B, Qi S, Shen J. Chen H, et al. Among authors: luo y. Chin Med. 2022 Apr 27;17(1):51. doi: 10.1186/s13020-022-00595-7. Chin Med. 2022. PMID: 35477576 Free PMC article.

10

Ultrasound-responsive nanoparticles for nitric oxide release to inhibit the growth of breast cancer.

Yang H, Zheng G, Li G, Chen J, Qi L, Luo Y, Ke T, Xiong J, Ji X. Yang H, et al. Among authors: luo y. Cancer Cell Int. 2024 Dec 28;24(1):434. doi: 10.1186/s12935-024-03627-4. Cancer Cell Int. 2024. PMID: 39732688

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29,602 results

Search Page

Filters